Amendment No.1 to Employment Agreement between Mark Winderlich and HOOKIPA Biotech GmbH, dated December 30, 2023
Exhibit 10.2
AMENDMENT NO. 1 TO THE EMPLOYMENT AGREEMENT
This Amendment No. 1 (“Amendment”) is a modification of the Employment Agreement by and between HOOKIPA Biotech GmbH (the “Company”), and Mark Winderlich, PhD MSc (the “Executive”), effective as of June 1, 2024 (“Agreement”).
The parties wish to have the Agreement enter into effect two months earlier, so that the new Effective Date shall be April 1, 2024.
Accordingly, the parties hereby agree to change the Effective Date from June 1, 2024 to April 1, 2024.
This Amendment is made according to Section 17 of the Agreement. This Amendment is to be construed consistently insofar as possible with the Agreement, but in the event of a conflict, this Amendment shall control. Any capitalized terms used herein shall have the same meaning as set forth for such terms in the Agreement.
All other terms and conditions of the Agreement remain unchanged and in full force.
IN WITNESS WHEREOF, the parties hereby have executed this Amendment the day and year written below.
HOOKIPA Biotech GmbH |
| EXECUTIVE | ||||||
| | | ||||||
By: | | | By: | | ||||
Name: | Jörn Aldag | | Name: | Mark Winderlich, PhD MSc | ||||
Title: | Chief Executive Officer | | | |||||
Date: | | December 13, 2023 | | Date: | | December 30, 2023 |